Q: My doctor heard a new heart murmur and suspected I have a narrowed valve due to aortic stenosis. I feel fine. Why did this ...

Fibrosis predicts post-surgical risk in aortic stenosis, reinforcing its role in guiding treatment decisions for both sexes.

The nitric oxide-independent soluble guanylate cyclase activator ataciguat continued to show promise for slowing the ...

The phase II data are promising for patients who are managed with watchful waiting before being offered an intervention.

If validated prospectively, the findings could be ‘transformative’ for patients with no current medical options.

Sue Dumbauld's job was straining her heart. After losing weight, improving her cholesterol, she was in great shape for ...

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCut™ - the world's first ...

Ataciguat, a new drug being studied for aortic valve stenosis, shows promise in slowing disease progression and reducing the ...

The collaboration aims to upskill over 300 cardiologists and radiologists in echocardiography and MRI, with a focus on ...